找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Immunosurveillance, Immunodeficiencies and Lymphoproliferations; Lymphoproliferative Stephan H. Oertel,Hanno Riess Conference proceedings

[复制链接]
楼主: INEPT
发表于 2025-3-26 22:40:32 | 显示全部楼层
H. B. Gaspar,P. Amrolia,A. Hassan,D. Webb,A. Jones,N. Sturt,G. Vergani,A. Pagliuca,G. Mufti,N. Hadzi.Authoritative and thorough, .Clinical Applications of Mass Spectrometry in Drug Analysis: Methods and Protocols, .is a great resource for laboratorians who are already using mass spectrometry or thinking of introducing this technology to their laboratories..
发表于 2025-3-27 03:32:40 | 显示全部楼层
David J. Strausonance imaging) have been categorized and condensed into a format that will be both comprehensible and useful on a daily basis for those physicians routinely requesting these diagnostic examina­ tions for their patients. For simplicity, the book is divided, whenever feasible, into organ systems and
发表于 2025-3-27 08:27:01 | 显示全部楼层
发表于 2025-3-27 12:56:00 | 显示全部楼层
easure of the amount of analyte originally present. For theroetical and practical reasons this type of assay was not widely accepted and a variant of the basic system became more popular. This is the so-called two-site immunoradiometric assay (Woodhead et al, 1974) in which antigen is bound by label
发表于 2025-3-27 16:11:36 | 显示全部楼层
发表于 2025-3-27 18:50:11 | 显示全部楼层
发表于 2025-3-27 23:51:50 | 显示全部楼层
发表于 2025-3-28 04:22:50 | 显示全部楼层
,NF-κB Inhibition in EBV-Transformed Lymphoblastoid Cell Lines,ily member, is diminished after NF-κB inhibition whereas Bcl–2 and Bcl-x/L expression is unaffected. These studies suggest that NFκB itself, or NF-κB-regulated genes, will be successful molecular targets for the treatment of EBV-associated diseases.
发表于 2025-3-28 06:39:56 | 显示全部楼层
发表于 2025-3-28 13:41:05 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-18 11:39
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表